|
source DB |
source ID
|
text
|
size
|
updated at |
|
# proj.
|
|
# Ann.
|
updated_at |
| PMC |
7156805 |
COVID-19 and immunomodulator/immunosuppressant use in dermatology
To the Editor: We read with great |
8.22 KB |
2020-09-27 |
|
17 |
|
20 |
-
|
| PMC |
7163172 |
PET imaging of COVID-19: the target and the number
In the context of COVID-19 worldwide outbreak, f |
4.01 KB |
2020-09-27 |
|
19 |
|
16 |
-
|
| PMC |
7166030 |
Elevated Troponin in Patients With Coronavirus Disease 2019: Possible Mechanisms
Abstract
Coronavir |
16.4 KB |
2020-09-27 |
|
20 |
|
161 |
-
|
| PMC |
7162775 |
Features of anosmia in COVID-19
Highlights
• Fifty-four of 114 patients (47%) with confirmed COVID |
13.3 KB |
2020-09-27 |
|
20 |
|
125 |
-
|
| PMC |
7161517 |
Clinical Implications of SARS-CoV-2 Interaction With Renin Angiotensin System
JACC Review Topic of t |
33.1 KB |
2020-09-27 |
|
20 |
|
179 |
-
|
| PMC |
7156578 |
Declining Public Health Protections within Autocratic Regimes: Impact on Global Public Health Securi |
51.3 KB |
2020-09-27 |
|
17 |
|
85 |
-
|
| PMC |
7163347 |
The application of strong matrix management and PDCA cycle in the management of severe COVID-19 pati |
7.56 KB |
2020-09-27 |
|
20 |
|
14 |
-
|
| PMC |
7157814 |
Hiding in Plain Sight: an Approach to Treating Patients with Severe COVID-19 Infection
Commentary
P |
5.49 KB |
2020-09-27 |
|
20 |
|
54 |
-
|
| PMC |
7163348 |
Einstellung von Patienten mit entzündlich-rheumatischen Erkrankungen zur immunsuppressiven Therapie |
12.4 KB |
2020-09-27 |
|
17 |
|
37 |
-
|
| PMC |
7166305 |
Letter to the Editor: Low-density lipoprotein is a potential predictor of poor prognosis in patients |
13.3 KB |
2020-09-27 |
|
20 |
|
75 |
-
|
